Recombinant Mouse LARS2 Protein，His

LARS2 (Leucyl-tRNA synthetase 2) is a mitochondrial enzyme that plays a critical role in the protein synthesis machinery of mitochondria by charging tRNA with the amino acid leucine. Its importance extends beyond basic translation processes, as mutations in the LARS2 gene have been implicated in various mitochondrial disorders, contributing to a complex clinical picture that includes neurological deficits, myopathy, and multi-organ dysfunction. Research on LARS2 has gained momentum due to the enzyme's essential contributions to mitochondrial function and its involvement in cellular energy metabolism. Scientists are increasingly focused on understanding the structure-function relationship of LARS2, characterizing its enzymatic activity, and elucidating the impact of mutations at both molecular and systemic levels. Additionally, the study of LARS2 is crucial for developing potential therapeutic strategies, including gene therapy and mitochondrial targeted interventions, to ameliorate the effects of LARS2-related diseases. As mitochondrial dysfunction is a central feature of numerous age-related and degenerative diseases, understanding the role of LARS2 in mitochondrial health could open new avenues for research and treatment. Overall, the exploration of LARS2 and its recombinant protein form is pivotal for gaining insights into mitochondrial biology and developing innovative strategies to combat mitochondrial disorders.